The firm remains bullish on the stock, noting it is trading at a discount to the average of peer names in household and personal care.
Get this delivered to your inbox, and more info about our products and services.
BofA analysts are bullish on this German medtech name ahead of its full-year earnings report.
The bank pointed to recent M&A success as a catalyst for the stock.
The beauty retailer's investments seem poised to pay off, according to analyst Lorraine Hutchinson.
Bank of America named five stocks that are well positioned despite a turbulent macroeconomy.
Shares have pulled back more than 22% in 2025.
The bank said concerns about a previous acquisition and a relatively strong position to navigate GLP-1s means the stock is a buy.
